Namulema Edith, Davis Birch William, Nakiriba Mayega Rhoda, Namugga Barbara, Musasizi Racheal, Tumwesigye Ambrose, Littlejohns Anna, Please Helen, Sharma Vishal, Cunningham Alice, Waters Ian, Brettle David, Parmar Jiten D, Miller Roy, Beacon Tim, Murdoch Stuart, Culmer Peter, Kapur Nikil, Winton Mark, Lawton Tom
Mengo Hospital, Kampala, Uganda.
University of Leeds, School of Mechanical Engineering, Leeds, UK.
ERJ Open Res. 2025 Jun 30;11(3). doi: 10.1183/23120541.00673-2024. eCollection 2025 May.
Continuous positive airway pressure (CPAP) is a well-established treatment modality for children in moderate and severe respiratory failure in well-resourced settings. However, the availability of CPAP is generally poor in many resource-limited settings, in large part because existing CPAP devices are not designed for cost and resource efficiency, which precludes their use. The LeVe CPAP System has been co-developed by an international multidisciplinary team specifically for use in low-resource settings. In this paper we report the first study evaluating the efficacy of using the LeVe CPAP System as an intervention for children with acute hypoxaemic respiratory failure at Mengo Hospital in Kampala, Uganda.
A total of 42 paediatric patients were recruited onto the study, all of whom were failing to maintain oxygen saturation above 88% at room conditions. Key clinical measures, including oxygen saturation, heart rate, respiratory rate and dyspnoea were recorded every hour for the length of admission on the paediatric ward.
At completion, 39 patients had recovered and were successfully discharged while 3 of 42 (7%) died in the early phases of treatment. Surviving patients showed improvements in all clinical measures, particularly in the first 12 h of treatment, and no adverse effects were reported after continued use. Additionally, we interviewed five parents whose children were undergoing treatment to gain a qualitative assessment of perceptions to the LeVe CPAP System.
Outcomes of the study demonstrate the capability of the LeVe CPAP System to treat paediatric patients in respiratory failure and support the system's wider adoption in low-resource settings.
在资源充足的环境中,持续气道正压通气(CPAP)是治疗中重度呼吸衰竭儿童的一种成熟治疗方式。然而,在许多资源有限的环境中,CPAP的可用性普遍较差,很大程度上是因为现有的CPAP设备在设计上未考虑成本和资源效率,这使得它们无法得到应用。LeVe CPAP系统是由一个国际多学科团队共同开发的,专门用于资源匮乏地区。在本文中,我们报告了第一项评估LeVe CPAP系统作为干预手段治疗乌干达坎帕拉门戈医院急性低氧性呼吸衰竭儿童疗效的研究。
共有42名儿科患者被纳入该研究,所有患者在室内条件下均无法维持氧饱和度在88%以上。在儿科病房住院期间,每小时记录一次关键临床指标,包括氧饱和度、心率、呼吸频率和呼吸困难情况。
研究结束时,39名患者康复并成功出院,42名患者中有3名(7%)在治疗早期死亡。存活患者的所有临床指标均有改善,尤其是在治疗的前12小时,持续使用后未报告不良反应。此外,我们采访了五名其孩子正在接受治疗的家长,以获得对LeVe CPAP系统看法的定性评估。
该研究结果证明了LeVe CPAP系统治疗呼吸衰竭儿科患者的能力,并支持该系统在资源有限地区更广泛地应用。